SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-18-065506
Filing Date
2018-12-20
Accepted
2018-12-20 07:26:08
Documents
1
Group Members
DAN ORENDEXCEL PHARMA TECHNOLOGIES LTD.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A tv509478_sc13da.htm SC 13D/A 75629
  Complete submission text file 0001144204-18-065506.txt   77322
Mailing Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS
Business Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS 441-295-5950
Axovant Sciences Ltd. (Subject) CIK: 0001636050 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: SC 13D/A | Act: 34 | File No.: 005-88883 | Film No.: 181244639
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 DEXCEL STREET OR AKIVA L3 30600000
Business Address 1 DEXCEL STREET OR AKIVA L3 30600000 972-4-636404
Dexxon Holdings Ltd. (Filed by) CIK: 0001636684 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D/A